Business | Gardiner Harris and Duff Wilson, New York Times | Wednesday October 27, 2010
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant -- the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines.Altogether, G...
www.ndtv.com/business